title: [Coagulation tests during treatment with Drotrecogin alpha (activated): do results reflect the clinical situation?].
authors.forename: A
authors.initials: A
authors.lastname: Roca de Togores López
authors.forename: R
authors.initials: R
authors.lastname: Armero Ibáñez
authors.forename: J M
authors.initials: JM
authors.lastname: Seller Losada
authors.forename: V
authors.initials: V
authors.lastname: Petusa Collado
authors.forename: X
authors.initials: X
authors.lastname: Onrubia Fuertes
authors.forename: C
authors.initials: C
authors.lastname: Sifre Julio
authors.forename: J
authors.initials: J
authors.lastname: Bellver Romero
authors.forename: M
authors.initials: M
authors.lastname: Barberá Alacreu
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D006801:Humans; D011486:Protein C / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D018805:Sepsis / Q000097:blood* / Q000188:drug therapy
chemical_list: D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated